Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tegileridine - Jiangsu Hengrui Medicine Co

Next Previous
X
Search
Drug Profile

Tegileridine - Jiangsu Hengrui Medicine Co

Alternative Names: SHR-8554; Tegileridine fumarate - Jiangsu Hengrui Medicine Co

Latest Information Update: 08 Jul 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jiangsu Hengrui Medicine Co.
  • Class Amines; Analgesics; Ethers; Naphthalenes; Pyridines; Small molecules; Spiro compounds
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Postoperative pain

Most Recent Events

  • 08 Jul 2024 Launched for Postoperative pain (IV), prior to July 2024 (Jiangsu Hengrui Medicine pipeline, July 2024)
  • 08 Jul 2024 Jiangsu HengRui Medicine submits New Drug Application (NDA) for the treatment of Postoperative pain (moderate to severe pain after orthopedic surgery), prior to July 2024 (Jiangsu HengRui Medicine pipeline, July 2024)
  • 20 Feb 2024 Chemical structure information added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top